Literature DB >> 21593437

Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B.

J H Lee1, S H Kim, G H Kim, S W Seo, H K Park, S J Oh, J S Kim, H K Cheong, D L Na.   

Abstract

BACKGROUND: Subcortical vascular dementia (SVaD) is considered the most common type of vascular dementia and often follows a slowly progressive course, simulating Alzheimer disease (AD). Whether the progressive cognitive decline is associated with pure SVaD or concomitant AD remains unknown. The purpose of this study was to determine what proportion of patients with SVaD lack abnormal amyloid imaging, and to examine differences in the clinical or MRI features between subjects with SVaD with cortical amyloid deposition and those without.
METHODS: We measured brain amyloid deposition using (11)C-Pittsburgh compound B (PiB) PET in 45 patients (men: women = 19:26; mean age 74.2 ± 7.6 years) with SVaD. They all met DSM-IV criteria for vascular dementia and had severe white matter high signal intensities without territorial infarction or macrohemorrhage on MRI.
RESULTS: Thirty-one (68.9%) of 45 patients with SVaD were negative for cortical PiB binding. There was significant difference between (11)C-PiB-positive and (11)C-PiB-negative groups in terms of age (79.5 vs 71.9 years), Mini-Mental State Examination score (18.6 vs 22.6), the number of lacunes (3.9 vs 9.0), and the visual rating scale of hippocampal atrophy (3.1 vs 2.3). The neuropsychological assessments revealed that patients with (11)C-PiB-negative SVaD performed better on the delayed recall of both the verbal and visual memory test than did those with (11)C-PiB-positive scan.
CONCLUSION: SVaD without abnormal amyloid imaging was more common than expected. Patients with SVaD with and without abnormal amyloid imaging differed in clinical and MRI features, although there was considerable overlap.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593437     DOI: 10.1212/WNL.0b013e318221acee

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  59 in total

1.  Cerebrovascular disease, β-amyloid, and cognition in aging.

Authors:  Natalie L Marchant; Bruce R Reed; Charles S DeCarli; Cindee M Madison; Michael W Weiner; Helena C Chui; William J Jagust
Journal:  Neurobiol Aging       Date:  2011-11-01       Impact factor: 4.673

2.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

3.  Vascular Dementia.

Authors:  Alberto R Ramos; Salim I Dib; Clinton B Wright
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2013-09-01

4.  Individual subject classification of mixed dementia from pure subcortical vascular dementia based on subcortical shape analysis.

Authors:  Hee Jin Kim; Jeonghun Kim; Hanna Cho; Byoung Seok Ye; Cindy W Yoon; Young Noh; Geon Ha Kim; Jae Hong Lee; Jae Seung Kim; Yearn Seong Choe; Kyung-Han Lee; Chang-Hun Kim; Sang Won Seo; Michael W Weiner; Duk L Na; Joon-Kyung Seong
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

5.  Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Authors:  Hee Jin Kim; Seongbeom Park; Hanna Cho; Young Kyoung Jang; Jin San Lee; Hyemin Jang; Yeshin Kim; Ko Woon Kim; Young Hoon Ryu; Jae Yong Choi; Seung Hwan Moon; Michael W Weiner; William J Jagust; Gil D Rabinovici; Charles DeCarli; Chul Hyoung Lyoo; Duk L Na; Sang Won Seo
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

6.  Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers.

Authors:  Tessandra Stewart; Min Shi; Aanchal Mehrotra; Patrick Aro; David Soltys; Kathleen F Kerr; Cyrus P Zabetian; Elaine R Peskind; Peggy Taylor; Leslie M Shaw; John Q Trojanowski; Jing Zhang
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Clinical effect of white matter network disruption related to amyloid and small vessel disease.

Authors:  Hee Jin Kim; Kiho Im; Hunki Kwon; Jong-Min Lee; Changsoo Kim; Yeo Jin Kim; Na-Yeon Jung; Hanna Cho; Byoung Seok Ye; Young Noh; Geon Ha Kim; En-Da Ko; Jae Seung Kim; Yearn Seong Choe; Kyung Han Lee; Sung Tae Kim; Jae Hong Lee; Michael Ewers; Michael W Weiner; Duk L Na; Sang Won Seo
Journal:  Neurology       Date:  2015-06-10       Impact factor: 9.910

8.  Predicting Regional Pattern of Longitudinal β-Amyloid Accumulation by Baseline PET.

Authors:  Tengfei Guo; Matthias Brendel; Timo Grimmer; Axel Rominger; Igor Yakushev
Journal:  J Nucl Med       Date:  2016-10-06       Impact factor: 10.057

9.  Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment.

Authors:  Mi Ji Lee; Sang Won Seo; Duk L Na; Changsoo Kim; Jae Hyun Park; Geon Ha Kim; Chi Hun Kim; Young Noh; Hanna Cho; Hee Jin Kim; Cindy W Yoon; Byoung Seok Ye; Juhee Chin; Seun Jeon; Jong-Min Lee; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Sung Tae Kim; Jae-Hong Lee; Michael Ewers; David J Werring; Michael W Weiner
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

Review 10.  Vascular Cognitive Impairment.

Authors:  Jonathan Graff-Radford
Journal:  Continuum (Minneap Minn)       Date:  2019-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.